Found 63 matching trials
The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver Disease
PHASE2The role of Helicobacter pylori(HP)in the pathogenesis of non-alcoholic fat...
Location
Gastroenterology clinic, Sina Hospital
Personalized Treatment for Refractory H Pylori Infection
NAIn this study, the investigators develop a personalized treatment according...
Location
Kaohsiung Veterans General Hospital
Tegoprazan- Versus PPI-based H. Pylori Eradication
N/AIn 2015, vonoprazan, a potassium-competitive blocker (P-CAB), was launched ...
Location
Digestive Disease Center, Soonchunhyang University Hospital
Prospective Randomised Trial of First and Second Line Treatments of RCT of First and Second Line H Pylori Treatments in Slovenia
NAStudy is prospective randomised multicentric. The primary objective of the ...
Treatments Being Tested
Esomeprazole 40mg, Clarithromycin 500 mg, Metronidazole 400 mg,Esomeprazole 40mg, Bismuth subcitrate 120 mg, Amoxicillin 500 mg, Metronidazole 400 mgEsomeprazole 40mg, Bismuth subcitrate 120 mg, Amoxicillin 500 mg, Metronidazole 400 mgEsomeprazole 40mg, Amoxicillin 500 mg, Levofloxacin 500 mg Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
PHASE2RATIONALE: Antibiotics may stop the growth of Helicobacter pylori which may...
Location
Royal United Hospital
A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients
PHASE4The purpose of this study is to assess and compare the effectiveness and sa...
Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori Infection
PHASE3The purpose of this study is to demonstrate the non-inferior efficacy of TA...
Location
The First Affiliated Hospital of Anhui Medical University
TAK-438 Bismuth Drug Interaction Study
PHASE1To evaluate the safety, tolerability, and pharmacokinetics (PK) of quadrupl...
Location
Multiple Locations
Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers
PHASE1This study aims to evaluate the pharmacokinetic interaction between tegopra...
Location
Chonbuk National University Hospital
ADDITION OF BISMUTH TO THE STANDARD TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION
PHASE2H pylori is an important cause of chronic gastritis and other complications...
Location
Ziauddin University Hospital